These findings emphasized that TRZ can alleviate AD neuropathology either directly by inhibiting Aβ-induced neurodegeneration and associated neuroinflammation and oxidative stress or indirectly by reducing BIR. Here, KCNJ11 is linked to Alzheimer disease.